Skip to main content
. 2022 Apr 13;9:838654. doi: 10.3389/fmolb.2022.838654

FIGURE 8.

FIGURE 8

Therapeutic response and drug sensitivity analysis. (A) Patients in the high-risk group showed significant docetaxel resistance. (B) Sensitivity analysis of genes in “E2F target”-related signature and common drugs of prostate cancer. (C) Drug sensitivity analysis showed that the top 16 drugs in the CellMiner database, which were sensitive to genes in “E2F target”-related signature.